iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta

Yunfeng Ding,Sean P. Palecek,Eric V. Shusta
DOI: https://doi.org/10.1186/s12987-024-00580-2
2024-10-13
Fluids and Barriers of the CNS
Abstract:Three common isoforms of the apolipoprotein E ( APOE ) gene - APOE2 , APOE3 , and APOE4 - hold varying significance in Alzheimer's Disease (AD) risk. The APOE4 allele is the strongest known genetic risk factor for late-onset Alzheimer's Disease (AD), and its expression has been shown to correlate with increased central nervous system (CNS) amyloid deposition and accelerated neurodegeneration. Conversely, APOE2 is associated with reduced AD risk and lower CNS amyloid burden. Recent clinical data have suggested that increased blood-brain barrier (BBB) leakage is commonly observed among AD patients and APOE4 carriers. However, it remains unclear how different APOE isoforms may impact AD-related pathologies at the BBB.
neurosciences
What problem does this paper attempt to address?